Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BH-30236 by BlossomHill Therapeutics for Myelodysplastic Syndrome: Likelihood of Approval
BH-30236 is under clinical development by BlossomHill Therapeutics and currently in Phase I for Myelodysplastic Syndrome. According to GlobalData, Phase...